AI and GLP-1s: Transforming Obesity Care Through Digital Innovation Apr 14, 2025 4 min read By Brian Conyer REVOLUTIONIZING CLINICAL TRIALS AND REAL-WORLD RESEARCH The convergence of artificial intelligence (AI) and GLP-1 receptor agonists (GLP1-RA) is reshaping obesity treatment, creating unprecedented opportunities for innovation in clinical research, healthcare delivery, and patient care
Weekly injectable GLP-1 medications can be administered at any time of day, provided it's consistent from week to week
AnnaLisa Pastore, MD Center for Holistic & Integrative Medicine, Harrington Park, NJ Remove Toxins
Antioxidant peptides scavenge free radicals, shielding membranes, mitochondria, and sperm nuclear DNA
Inflammation and GLP-1s Chronic low-grade inflammation, also known as "inflammaging," is a common feature of many chronic diseases, including metabolic disorders, autoimmune conditions, and cardiovascular disease
If you are pregnant, an athlete or have concerns, please speak to a clinician